THE PARKINSONIAN 6 HYDROXYDOPAMINE MODEL

帕金森病 6 羟多巴胺模型

基本信息

  • 批准号:
    6629343
  • 负责人:
  • 金额:
    $ 25.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-02-20 至 2005-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (applicant's abstract): Parkinson's disease is the most common debilitating movement disorder of the aging human population. The neurons that degenerate in Parkinson's disease are subject to increased oxidative stress because superoxide and other reactive species are generated during dopamine metabolism. 6-hydroxydopamine (6-OHDA) is a redox cycling dopamine analog, which can be targeted to selectively damage the nigrostriatal system that degenerates in Parkinson's disease. Phosphotyrosine signaling pathways activated by neuroprotective factors, such as brain derived neurotrophic factor and glial cell line-derived neurotrophic factor, are important for dopaminergic neuron function and survival. This proposal is designed to investigate the hypothesis that oxidant-mediated alterations in phosphotyrosine signaling contribute to degeneration of dopaminergic neurons in Parkinson's disease. Nitrotyrosine, a marker of oxidative stress involving peroxynitrite formation, is increased in both the 6-OHDA rodent model and in human Parkinsonian brain tissues. Peroxynitrite is formed from the reaction of superoxide with nitric oxide, implicating these free radicals in the pathogenesis of Parkinson's disease. In this proposal, mechanisms by which 6-OHDA, superoxide, and nitric oxide affect phosphotyrosine signaling cascades will be investigated using immortalized dopaminergic neuron lines and mice with genetically altered levels of extracellular superoxide dismutase. This comprehensive set of studies will yield important insights concerning mechanisms by which oxidative stress affects neurotrophic signaling in dopaminergic neurons, potentially contributing to development of combined antioxidant-neurotrophic factor therapies for Parkinson's disease.
描述(申请人摘要):帕金森病是最常见的疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charleen T Chu其他文献

PSS75 - Functional Roles of Distinct Subcellular Pools of PTEN Induced Kinase-1 on Oxidative Stress and Mitochondrial Function
  • DOI:
    10.1016/j.freeradbiomed.2013.10.491
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ruben K Dagda;Aaron Gusdon;Charleen T Chu
  • 通讯作者:
    Charleen T Chu
Propofol affects mouse embryonic fibroblast survival and proliferation in vitro via ATG5- and calcium-dependent regulation of autophagy
异丙酚通过 ATG5 和钙依赖性自噬调节影响体外小鼠胚胎成纤维细胞的存活和增殖
  • DOI:
    10.1038/s41401-019-0303-z
  • 发表时间:
    2019-10
  • 期刊:
  • 影响因子:
    8.2
  • 作者:
    Zhen-dong Xu;Yong Wang;Ge Liang;Zhi-qiang Liu;Wu-hua Ma;Charleen T Chu;Hua-feng Wei
  • 通讯作者:
    Hua-feng Wei
Propofol affects mouse embryonic fibroblast survival and proliferation in vitro via ATG5- and calcium-dependent regulation of autophagy
  • DOI:
    https://doi.org/10.1038/s41401-019-0303-z
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
  • 作者:
    Zhen-dong Xu;Yong Wang;Ge Liang;Zhi-qiang Liu;Wu-hua Ma;Charleen T Chu;Hua-feng Wei
  • 通讯作者:
    Hua-feng Wei

Charleen T Chu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charleen T Chu', 18)}}的其他基金

Protein homeostasis in a frontotemporal dementia iPSC model
额颞叶痴呆 iPSC 模型中的蛋白质稳态
  • 批准号:
    10525437
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
Dendrite regulation by the mitochondrial kinase PINK1: Implications for PD/LBD
线粒体激酶 PINK1 的树突调节:对 PD/LBD 的影响
  • 批准号:
    9973247
  • 财政年份:
    2017
  • 资助金额:
    $ 25.88万
  • 项目类别:
Dendrite regulation by the mitochondrial kinase PINK1: Implications for PD/LBD
线粒体激酶 PINK1 的树突调节:对 PD/LBD 的影响
  • 批准号:
    10199062
  • 财政年份:
    2017
  • 资助金额:
    $ 25.88万
  • 项目类别:
Regulation of Autophagy & Mitochondrial Recycling in Neuronal Cell Death
自噬的调控
  • 批准号:
    8500862
  • 财政年份:
    2013
  • 资助金额:
    $ 25.88万
  • 项目类别:
Regulation of Autophagy & Mitochondrial Recycling in Neuronal Cell Death
自噬的调控
  • 批准号:
    8841286
  • 财政年份:
    2013
  • 资助金额:
    $ 25.88万
  • 项目类别:
Regulation of Autophagy & Mitochondrial Recycling in Neuronal Cell Death
自噬的调控
  • 批准号:
    9269939
  • 财政年份:
    2013
  • 资助金额:
    $ 25.88万
  • 项目类别:
PINK1 Regulation of Neuronal and Mitochondrial Homeostasis
PINK1 对神经元和线粒体稳态的调节
  • 批准号:
    8269861
  • 财政年份:
    2011
  • 资助金额:
    $ 25.88万
  • 项目类别:
PINK1 Regulation of Neuronal and Mitochondrial Homeostasis
PINK1 对神经元和线粒体稳态的调节
  • 批准号:
    8697145
  • 财政年份:
    2011
  • 资助金额:
    $ 25.88万
  • 项目类别:
PINK1 Regulation of Neuronal and Mitochondrial Homeostasis
PINK1 对神经元和线粒体稳态的调节
  • 批准号:
    8181791
  • 财政年份:
    2011
  • 资助金额:
    $ 25.88万
  • 项目类别:
PINK1 Regulation of Neuronal and Mitochondrial Homeostasis
PINK1 对神经元和线粒体稳态的调节
  • 批准号:
    8501035
  • 财政年份:
    2011
  • 资助金额:
    $ 25.88万
  • 项目类别:

相似海外基金

Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
  • 批准号:
    2907463
  • 财政年份:
    2024
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
  • 批准号:
    MR/Y019415/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
  • 批准号:
    2898794
  • 财政年份:
    2024
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Studentship
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
  • 批准号:
    479285
  • 财政年份:
    2023
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Operating Grants
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
  • 批准号:
    23K10409
  • 财政年份:
    2023
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
  • 批准号:
    23K06928
  • 财政年份:
    2023
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Propagation of a-synuclein in Parkinson's disease progress
α-突触核蛋白在帕金森病进展中的传播
  • 批准号:
    22KJ2095
  • 财政年份:
    2023
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Drug-microbiome-host interactions in Parkinson's disease
帕金森病的药物-微生物组-宿主相互作用
  • 批准号:
    2881438
  • 财政年份:
    2023
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Studentship
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
  • 批准号:
    2884235
  • 财政年份:
    2023
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Studentship
MICA: How does the pedunculopone nucleus influence treatment responses in Parkinson's disease, and can it be targeted for new treatment strategies
MICA:脚核如何影响帕金森病的治疗反应,是否可以作为新治疗策略的目标
  • 批准号:
    MR/X005267/1
  • 财政年份:
    2023
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了